Short description of the study goes here. And be sure to update the link below to the new spotlight page you just created.
Situated among one of the world’s largest neuroscience communities, the Massachusetts General Hospital provides an array of neurotherapeutic treatments for our varied patient populations. Experts from the Department of Neurology, Department of Neurosurgery, Department of Psychiatry, the Athinoula A. Martinos Center for Biomedical Imaging and beyond develop and implement neurotherapeutics and associated diagnostics for individuals with complex brain disorders affecting cognition, behavior, emotion, sensory and motor functioning.
Neurological Clinical Research Institute (NCRI)
The ALS Multidisciplinary Clinic in the Healey Center for ALS at Mass General provides personalized care and access to the latest treatments and research opportunities for people with ALS, commonly known as Lou Gehrig’s disease.
The Mass General Epilepsy Service offers diagnosis, treatment, and consultations for seizure disorders, including surgical evaluations, and specialized care for first seizure events.
Massachusetts General Hospital provides deep brain stimulation as a treatment for a variety of neurological disorders, including XDP.
Our mission is to drive the development of new mechanism-driven therapies through a richer understanding of how neurologic disease affects behavior.
Our lab, led by Bakhos Tannous, PhD, focuses on molecular imaging, gene transfer technologies and high throughput screening aiming at finding novel therapeutics against brain tumors.
Our lab is focused on understanding neural repair mechanisms and outcomes after stroke in order to guide the development and clinical translation of novel neurotechnologies to optimize stroke recovery.
The Movement Disorders Unit at Mass General sees patients from around the world for everything from the most common to the rarest of movement disorders.
Clinical Trials Network and Institute (CTNI)
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital is dedicated to finding new treatments for bipolar disorder, providing high-quality clinical care and educating our colleagues, our patients, their families and the community about this disorder.
We use Electroconvulsive Therapy (ECT) to treat a number of psychiatric conditions, including depression.
The Division of Neurotherapeutics at Mass General focuses on neurotherapeutic interventions for severe, treatment-resistant psychiatric illnesses.
The Intravenous (IV) Ketamine Clinic for Depression at Massachusetts General Hospital offers patients and their professional providers access to ketamine treatment for severe and refractory depression.
The mission of the Pediatric Psychopharmacology and Adult ADHD Program at Massachusetts General Hospital is to advance the well-being of children and families afflicted with mental illness through research, education and clinical care.
The TMS Clinical Service at Massachusetts General Hospital provides non-invasive treatment for patients with major depressive disorder who are unable to find relief through antidepressant medications or psychotherapy.
Additional Neurotherapeutic Clinical Therapies and Research
Our neurosurgeons use deep brain stimulation (DBS) to treat patients with a wide variety of movement disorders.
The Visual Prosthesis Lab is working to create a means to restore sight to the blind by sending signals from a digital camera directly into the brain.
The Mass General for Children Epilepsy Surgery Program provides surgical evaluation and treatment for pediatric patients whose epilepsy cannot be managed with medical therapy or those for whom surgery is the best option overall.
For several decades the Massachusetts General Hospital Department of Neurosurgery and Department of Neurology have led in patient care for those with Parkinson's disease and advancing clinical research to develop new treatments with the hope of creating a cure.
Related News and Articles
- Nov | 16 | 2023
Jeffrey Schweitzer, MD, PhD, neurosurgeon, will virtually host an educational session addressing treatment options for individuals diagnosed with essential tremor and Parkinson's disease.
- Nov | 10 | 2023
Hakan Ay, MD, a stroke physician and an investigator in the department of Radiology is the senior author of a recently published paper in Annals of Neurology, Stroke-Related Visceral Alterations: A Voxel-Based Neuroanatomic Localization Study
- Oct | 23 | 2023
Research Spotlight: Telehealth for Psychiatry and Mental Healthcare Can Improve Access and Patient Outcomes
What are the benefits of this more widespread adaption of telehealth services for psychiatry, and what barriers still need to be addressed?
- Oct | 23 | 2023
Alexandra Touroutoglou, PhD and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital are the lead authors of a new study published in Alzheimer’s & Dementia
- Oct | 20 | 2023
Jonathan Rosand, MD, MSC, presented the McCance Center’s strategy, strengths and progress and the Brain Care Score at the Science Summit of the 78th United Nations General Assembly meetings in New York City.